“Double-Hit” Mature B-Cell Lymphomas Show a Common Immunophenotype by Flow Cytometry That Includes Decreased CD20 Expression
- 1 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 134 (2), 258-265
- https://doi.org/10.1309/ajcp7yldtjplce5f
Abstract
Lymphomas with 2 translocations involving c-MYC and BCL2 or BCL6 are a subset of biologically aggressive mature B-cell lymphomas now frequently categorized under the entity of B-cell lymphoma, unclassifiable, with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma. We identified a cohort of these lymphomas in our databases and retrospectively reviewed corresponding in-house flow cytometric data to determine whether a common immunophenotype might be present. Herein we report on our findings on 10 lymphomas, each with translocations involving c-MYC and BCL2 or BCL6 and show that these cases frequently showed a common immunophenotype that includes decreased expression of CD20. Because these lymphomas often show aggressive biologic behavior and poor clinical outcome, recognition of this relatively common immunophenotype may be useful for identifying cases for confirmatory cytogenetic studies, as often, flow cytometry provides the first assessment of these clinical specimens.Keywords
This publication has 19 references indexed in Scilit:
- B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell LymphomaThe American Journal of Surgical Pathology, 2010
- Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalBlood, 2009
- Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphomaJournal of Hematopathology, 2009
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocationsHaematologica, 2009
- Flow cytometric evaluation of CD38 expression assists in distinguishing follicular hyperplasia from follicular lymphomaCytometry Part B: Clinical Cytometry, 2009
- Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survivalBlood, 2009
- Bright CD38 expression is an indicator ofMYCrearrangementLeukemia & Lymphoma, 2009
- First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialBlood, 2008
- Ten‐Color Immunophenotyping of Hematopoietic CellsCurrent Protocols in Cytometry, 2005
- Gaining entry to the CNSNature Reviews Neuroscience, 2005